On the public citation graph
Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection After Transplantation
0 signed · 73 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/jmv.23539openalex-snapshot
High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy
inferredcites →https://doi.org/10.1002/lt.23991openalex-snapshot
Pretransplant Lymphopenia Is a Novel Prognostic Factor in Cytomegalovirus and Noncytomegalovirus Invasive Infections After Liver Transplantation
inferredcites →https://doi.org/10.1016/j.hemonc.2017.05.001openalex-snapshot
Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation
inferredcites →https://doi.org/10.1080/146532402317251473openalex-snapshot
Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation
inferredcites →https://doi.org/10.1093/cid/cit096openalex-snapshot
Virologic Suppression Measured by a Cytomegalovirus (CMV) DNA Test Calibrated to the World Health Organization International Standard Is Predictive of CMV Disease Resolution in Transplant Recipients
inferredcites →https://doi.org/10.1093/cid/ciw668openalex-snapshot
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
inferredcites →https://doi.org/10.1093/cid/ciy295openalex-snapshot
Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
inferredcites →https://doi.org/10.1097/mot.0b013e32834016b9openalex-snapshot
T-cell therapy for cytomegalovirus infection
inferredcites →https://doi.org/10.1097/tp.0000000000002396openalex-snapshot
Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients
inferredcites →https://doi.org/10.1111/ajt.12103openalex-snapshot
Cytomegalovirus in Solid Organ Transplantation
inferredcites →https://doi.org/10.1111/j.1399-0012.2009.01076.xopenalex-snapshot
The impact of invasive fungal diseases on survival after lung transplantation
inferredcites →https://doi.org/10.1172/jci90599openalex-snapshot
Immunotherapy for transplantation-associated viral infections
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4005580openalex-extracted
The Establishment of a CMV-Specific CD8 + T-Cell Threshold by Kinetic Modelling for Prediction of Post-HSCT Reactivation
inferred← citeshttps://doi.org/10.1002/ajh.26312openalex-snapshot
Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies
inferred← citeshttps://doi.org/10.1002/jmv.70949openalex-snapshot
Torque Teno Virus Viral Load as a Predictive Marker of Serotype‐Specific Antibody Response Following the 13‐Valent Conjugated Pneumococcal Vaccine in Adult Kidney Transplant Recipients: A Cohort Study
inferred← citeshttps://doi.org/10.1007/978-3-031-28797-8_10openalex-snapshot
Cytomegalovirus Diseases in Hematopoietic Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1016/j.ajt.2023.10.007openalex-snapshot
Risk of cytomegalovirus infection and subsequent allograft failure after pancreas transplantation
inferred← citeshttps://doi.org/10.1016/j.bneo.2025.100097openalex-snapshot
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab
inferred← citeshttps://doi.org/10.1016/j.clml.2026.05.008openalex-snapshot
Prospective Study of Cytomegalovirus Reactivation in Patients With Multiple Myeloma Receiving Anti-CD38 and BCMA Therapies
inferred← citeshttps://doi.org/10.1016/j.cmi.2022.07.001openalex-snapshot
Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium
inferred← citeshttps://doi.org/10.1016/j.cmi.2023.03.020openalex-snapshot
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2026.117651openalex-snapshot
Machine learning–driven analysis of CMV-DNA levels and associated factors
inferred← citeshttps://doi.org/10.1016/j.ekir.2026.107088openalex-snapshot
Cytomegalovirus: Updated Approach to Management for Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1016/j.ijid.2025.108311openalex-snapshot
Logical versus absolute lymphocyte count–guided preemptive therapy for cytomegalovirus prevention in kidney transplant recipients: a randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.isci.2022.105340openalex-snapshot
The establishment of a cytomegalovirus -specific CD8+ T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivation
inferred← citeshttps://doi.org/10.1016/j.jhlto.2023.100047openalex-snapshot
Cytomegalovirus infection in heart transplant recipients: Epidemiology, risk factors, and long-term outcomes from a major transplant center in the United States
inferred← citeshttps://doi.org/10.1016/j.semnephrol.2023.151486openalex-snapshot
Diagnosis, Prevention, and Treatment of Infections in Kidney Transplantation
inferred← citeshttps://doi.org/10.1016/j.transproceed.2019.01.129openalex-snapshot
Predictive Value of the Combination of Peripheral Blood Lymphocyte Count and Urinary Cytology in BK Polyomavirus–associated Nephropathy
inferred← citeshttps://doi.org/10.1016/j.trre.2024.100875openalex-snapshot
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
inferred← citeshttps://doi.org/10.1038/s41598-020-80790-4openalex-snapshot
Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
inferred← citeshttps://doi.org/10.1080/14787210.2020.1733976openalex-snapshot
Predictive tools to determine risk of infection in kidney transplant recipients
inferred← citeshttps://doi.org/10.1080/14787210.2024.2399647openalex-snapshot
Management of resistant and refractory cytomegalovirus infections after transplantation
inferred← citeshttps://doi.org/10.1080/1744666x.2024.2384060openalex-snapshot
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review
inferred← citeshttps://doi.org/10.1080/23808993.2021.1964951openalex-snapshot
Individualized management of cytomegalovirus in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1093/cid/ciaa1800openalex-snapshot
Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients
inferred← citeshttps://doi.org/10.1093/infdis/jiz452openalex-snapshot
Differences in Duration and Degree of Cytomegalovirus DNAemia Observed With Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care
inferred← citeshttps://doi.org/10.1093/jac/dkaf243openalex-snapshot
Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient
inferred← citeshttps://doi.org/10.1093/ofid/ofab199openalex-snapshot
Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
inferred← citeshttps://doi.org/10.1093/ofid/ofab248openalex-snapshot
A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants
inferred← citeshttps://doi.org/10.1093/ofid/ofag056openalex-snapshot
Diabetes Mellitus is a Risk Factor for Developing CMV Retinitis in Solid Organ Transplant Recipients: A Case-control Study
inferred← citeshttps://doi.org/10.1097/tp.0000000000004360openalex-snapshot
Absolute Lymphocyte Count as a Marker for Cytomegalovirus Infection After Heart Transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000004616openalex-snapshot
The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic…
inferred← citeshttps://doi.org/10.1097/tp.0000000000004855openalex-snapshot
What’s New: Updates on Cytomegalovirus in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000004870openalex-snapshot
QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1097/tp.0000000000004908openalex-snapshot
Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial
inferred← citeshttps://doi.org/10.1097/tp.0000000000005374openalex-snapshot
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1097/txd.0000000000001542openalex-snapshot
A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart Transplantation
inferred← citeshttps://doi.org/10.1097/txd.0000000000001846openalex-snapshot
Sex- and Age-based Comparison of Key Clinical Markers of Immunity After Heart and Kidney Transplantation
inferred← citeshttps://doi.org/10.1111/ctr.13512openalex-snapshot
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
inferred← citeshttps://doi.org/10.1111/ctr.15135openalex-snapshot
BK polyomavirus DNAemia in pancreas transplant recipients compared to pancreas–kidney recipients
inferred← citeshttps://doi.org/10.1111/ctr.15143openalex-snapshot
Clinical utility of a cytomegalovirus‐specific T cell assay in assessing the risk of post‐prophylaxis cytomegalovirus infection and post‐treatment relapse
inferred← citeshttps://doi.org/10.1111/ctr.70342openalex-snapshot
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
inferred← citeshttps://doi.org/10.1111/imr.70104openalex-snapshot
Sex Differences in Alloimmunity and Other Immunological Considerations in Organ Transplantation
inferred← citeshttps://doi.org/10.1111/tid.13189openalex-snapshot
The impact of recurrent cytomegalovirus infection on long‐term survival in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1111/tid.13489openalex-snapshot
Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a “Safe Corridor” after kidney transplantation?
inferred← citeshttps://doi.org/10.1111/tid.13864openalex-snapshot
Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard
inferred← citeshttps://doi.org/10.1111/tid.14020openalex-snapshot
Pathogen‐agnostic immune biomarkers that predict infection after solid organ transplantation
inferred← citeshttps://doi.org/10.1111/tid.14116openalex-snapshot
Like watching a soccer game through a keyhole: Cytomegalovirus cell‐mediated immunity incompletely reveals risk for clinically significant cytomegalovirus reactivation in cord blood transplant recipients
inferred← citeshttps://doi.org/10.1111/tid.14233openalex-snapshot
Five‐year single‐center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches
inferred← citeshttps://doi.org/10.1111/tid.14239openalex-snapshot
How low should we go? Potential and challenges of ultrasensitive CMV assays and solid organ transplantation
inferred← citeshttps://doi.org/10.1111/tid.70010openalex-snapshot
Impact of Severe Persistent BK Polyomavirus on Graft Function and Quality of Life Outcomes in Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1111/tid.70314openalex-snapshot
Incidence and Risk of Cytomegalovirus Infection After Intestine Transplantation
inferred← citeshttps://doi.org/10.1128/cmr.00043-19openalex-snapshot
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation
inferred← citeshttps://doi.org/10.11606/t.5.2023.tde-08052023-170032openalex-snapshot
Predição de infecção clinicamente relevante por citomegalovírus utilizando o teste Quantiferon-CMV em receptores de transplante renal CMV-soropositivos
inferred← citeshttps://doi.org/10.1182/bloodadvances.2020003074openalex-snapshot
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data
inferred← citeshttps://doi.org/10.1186/s12879-020-4787-4openalex-snapshot
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
inferred← citeshttps://doi.org/10.2147/idr.s547565openalex-snapshot
Beyond Thresholds: CMV Replication Kinetics as Early Predictors of Clinical Risk in Transplant Recipients
inferred← citeshttps://doi.org/10.3324/haematol.2019.229252openalex-snapshot
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.3389/ti.2023.11527openalex-snapshot
Utility of the Interferon-Gamma Enzyme-Linked Immunosorbent Spot Assay to Predict Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.3390/v16111781openalex-snapshot
Cytomegalovirus Infection After Solid Organ Transplantation: How I Use Cell-Mediated Immune Assays for Management
inferred← citeshttps://doi.org/10.36660/abc.20230588openalex-snapshot
Contagem Absoluta de Linfócitos: um Preditor de PCR Sérica Positiva para o Trypanosoma cruzi em Pacientes com Chagas Submetidos ao Transplante Cardíaco
inferred← citeshttps://doi.org/10.36660/abc.20230588iopenalex-snapshot
Absolute Lymphocyte Count: a Predictor of Positive Serum PCR for Trypanosoma cruzi in Patients with Chagas Disease Undergoing Heart Transplantation
inferred← citeshttps://doi.org/10.53730/ijhs.v6ns4.11814openalex-snapshot
Low absolute neutrophilic and lymphocytic counts in children with CMV reactivation following HSCT
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.